Rating History for Lisata Therapeutics, Inc (LSTA) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/21/2026 | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
2.16 (3.48) |
61.11% | Details |
 |
|||||||
